Akash Jaiswal: Anemia in the Elderly – Is It Truly Age Related or a Missed Diagnosis?
Akash Jaiswal, Consultant Geriatric Medicine at Fortis Healthcare, shared a post on LinkedIn:
“Anemia in the Elderly: Just ‘Age-related’ or a Missed Diagnosis?
Geriatric Anemia Series | Part 1
An 82-year-old walks into the OPD with Hb of 9 g/dL which has been slowly decreasing over last one year from 11.
No other active complaints apart from fatigue.
‘Stable for age.’
Already on iron supplements for months.
Anemia is NOT a normal part of aging.
Yes, you may hear the term ‘anemia of ageing.’
But in reality, this is often a diagnosis of exclusion and not a justification to stop evaluating.
Why this matters
Even ‘mild’ anemia in older adults is associated with:
- Increased falls
- Cognitive decline
- Frailty
- Higher hospitalization rates
- Increased mortality
In geriatrics, anemia is not just a number. It is a prognostic marker.
Most cases fall into 3 broad categories:
Nutritional
- Iron
- Vitamin B12
- Folate
Chronic disease / inflammation
- CKD
- Chronic infections
- Malignancy
Bone marrow disorders
- Myelodysplastic syndromes (MDS)
- Hematological malignancies
- Aplastic Anemia
‘Anemia of aging’ as a final diagnosis is only acceptable after a systematic, documented exclusion of the above causes.
It constitute around 1/3rd of cases of Anemia in elderly.
Common mistake I see in practice
‘Empirical iron therapy without diagnosis.’
Meanwhile, the underlying cause remains missed.
When should you pause and think deeper?
- New-onset anemia in an elderly patient
- No clear nutritional deficiency
- Incomplete response to iron/B12
- Associated weight loss or fatigue out of proportion
Clinical takeaway
Every anemia in the elderly deserves an explanation.
Because sometimes, What looks like ‘simple anemia’ is the first clue to something sinister.
Over the coming weeks, I’ll be breaking down key aspects of anemia in the elderly, one clinically relevant topic at a time.
Stay connected.”
Stay updated with Hemostasis Today.
-
Jul 6, 2026, 19:25Ambreen Kashif: Highlighting the Impact of Temporary Donor Deferrals on Donor Retention
-
Jul 6, 2026, 19:23Rob Mac Sweeney: Anticoagulation Strategies for Cardiopulmonary Bypass in Heparin-Induced Thrombocytopenia
-
Jul 6, 2026, 19:22Nthabiseng Bapela: Interpreting INR in Patients on Warfarin – A Practical Clinical Framework
-
Jul 6, 2026, 19:20Hamza Mohamed: Key Highlights from the 2026 AHA/ACC Multisociety Guideline on Acute PE
-
Jul 6, 2026, 18:58Mostafa Faisal: High PNH Type II Neutrophil Proportions Are Associated With Thrombosis
-
Jul 6, 2026, 17:57When Hematocrit Exceeds 70 Percent: Challenges in Peripheral Blood Smear Evaluation and CBC Analysis – Seema Dawood
-
Jul 6, 2026, 17:382026 ACC/AHA Multisociety Dyslipidemia Guideline: Key Updates for Vascular Specialists – Batool Abuhalimeh
-
Jul 6, 2026, 17:27Nicolas Gendron: Should Carbon Footprint Influence Therapeutic Decisions?
-
Jul 6, 2026, 17:15Sanchit Sharma։ Continuous Anticoagulation in PVT with Varices